NFKB1 and thyroid cancer: Cytoplasmic HMGB3 activates nucleic acid-mediated TLR3/NF-κB signaling, and extracellular HMGB3 interacts with the transmembrane receptor triggering receptor expressed on myeloid cells (TREM1 and CD354) in thyroid cancer.